Stay updated on Inactivated Vaccine for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Inactivated Vaccine for COVID-19 Clinical Trial page.

Latest updates to the Inactivated Vaccine for COVID-19 Clinical Trial page
- Check5 days agoChange DetectedThe record presents details of Sinovac’s completed Phase 1/2 study evaluating the safety and immunogenicity of an inactivated COVID-19 vaccine in adults aged 60 and older. It includes the study design, participant criteria, vaccine groups, outcomes, locations, and record dates.SummaryDifference52%

- Check12 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 error.SummaryDifference0.2%

- Check19 days agoChange DetectedA notice about NIH’s website transition and its terminology for artificial intelligence appears above the 403 error page.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page remains a 403 error screen without study details.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the study page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating access to the trial information is blocked. This changes the page from presenting study content to signaling an access restriction.SummaryDifference19%

Stay in the know with updates to Inactivated Vaccine for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inactivated Vaccine for COVID-19 Clinical Trial page.